Cancer drugs have become increasingly expensive in recent years. No one blinks anymore when a new lung cancer or colon cancer treatment comes to market priced at more than $100,000 per patient. In part, we don’t blink because we have simply gotten used to such prices – the shock has worn off. Moreover, many of…
Here is a figure reproduced in Fortune, showing that when researchers publish articles raising questions about the harms of salt, they cite other researchers who raised similar questions. By contrast, when they definitively argue in favor of the harms, they cite other definitive colleagues. Some of this makes scientific sense. If you show a particular…
Tired of all those family newsletters that inundate you with overwhelming detail on all the amazing accomplishments of your friends’ children? I thought I would address that issue, in my latest edition of my own family newsletter. Hope you enjoy: Ubel/Greeno Annual Holiday Letter.
Mammograms for breast cancer; the PSA blood test for prostate cancer; CT scans for lung cancer; and things like stool blood tests and colonoscopies for colon cancer. Each of these screening tests is designed to find cancers, or precancers, before they become symptomatic, the goal of early detection being to enable clinicians to eradicate growths…
Last year, I joined Zeke Emanuel and some other great people in publishing an article on how to use the insights of behavioral economics to nudge physicians towards providing high-value care. Here is a link to that article. To give you a teaser, here are some of the principles we drew upon: And here are…
Taste versus health: That’s a trade-off we are often faced with when deciding what to eat. Some foods are bad for our health but happen to taste quite good. All of us have limited willpower, and when we are exhausted those unhealthy foods become harder to resist. But did you know that when willpower is depleted,…